Articles

• How does the Purdue deal compare to the largest settlements in pharma history?

  Purdue Pharma is pushing for a massive settlement to deal with thousands of opioid-related lawsuits.

• How Novartis’ data manipulation case is a cautionary tale for transparency

  “Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.

• 7 of the biggest pharma bankruptcies this year

  What’s causing drug companies to go bust

• The surge in cancer drug approvals — By the numbers

  A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?